BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28860785)

  • 1. The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients.
    Liu SH; Chen CY; Li YJ; Wu HH; Lin CY; Chen YC; Chang MY; Hsu HH; Ku CL; Tian YC
    Ther Clin Risk Manag; 2017; 13():1009-1021. PubMed ID: 28860785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.
    Liu SH; Li YJ; Wu HH; Lee CC; Lin CY; Weng CH; Chen YC; Chang MY; Hsu HH; Fang JT; Hung CC; Yang CW; Tian YC
    PLoS One; 2014; 9(3):e93063. PubMed ID: 24667814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Adiponectin with High-Sensitivity C-Reactive Protein and Clinical Outcomes in Peritoneal Dialysis Patients: A 3.5-Year Follow-Up Study.
    Tung CW; Hsu YC; Shih YH; Lin CL
    PLoS One; 2015; 10(10):e0141058. PubMed ID: 26474473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
    Wang AY; Woo J; Lam CW; Wang M; Sea MM; Lui SF; Li PK; Sanderson J
    J Am Soc Nephrol; 2003 Jul; 14(7):1871-9. PubMed ID: 12819248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Sensitivity Troponin T and C-Reactive Protein Have Different Prognostic Values in Hemo- and Peritoneal Dialysis Populations: A Cohort Study.
    Chen T; Hassan HC; Qian P; Vu M; Makris A
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammation modulates the ability of serum ferritin to predict all-cause and cardiovascular mortality in peritoneal dialysis patients.
    Fu S; Chen J; Liu B; Liang P; Zeng Y; Feng M; Xu Z; Zheng G; Yang S; Xu A; Tang Y
    BMC Nephrol; 2020 Jun; 21(1):237. PubMed ID: 32576274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients.
    Ateş K; Ateş A; Ekmekçi Y; Nergizoglu G
    Perit Dial Int; 2005; 25(3):256-68. PubMed ID: 15981774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients.
    Li W; Xiong L; Fan L; Wang Y; Peng X; Rong R; Qiu Y; Shen J; Lin J; Yu X; Mao H
    BMC Nephrol; 2017 Jul; 18(1):211. PubMed ID: 28676043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Serum Uric Acid and High-Sensitivity C Reactive Protein Concentrations Predict Three-Year Cardiovascular Mortality in Patients Treated With Continuous Ambulatory Peritoneal Dialysis.
    Dao Bui Quy Q; Pham Ngoc Huy T; Nguyen Minh T; Nguyen Duc L; Nguyen Minh T; Nguyen Trung K; Tran Viet T; Do Q; Le Viet T
    Cureus; 2021 Sep; 13(9):e17900. PubMed ID: 34532198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.
    Avram MM; Fein PA; Paluch MM; Schloth T; Chattopadhyay J
    Adv Perit Dial; 2005; 21():154-8. PubMed ID: 16686309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of C-reactive protein and pulse pressure evaluated at the start of peritoneal dialysis on cardiovascular events in the course of treatment with peritoneal dialysis.
    Han SS; Ahn JM; Chin HJ; Chae DW; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S; Na KY
    Perit Dial Int; 2010; 30(3):300-10. PubMed ID: 20190029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients.
    Yokoyama K; Yoshida H; Matsuo N; Maruyama Y; Kawamura Y; Yamamoto R; Hanaoka K; Ikeda M; Yamamoto H; Nakayama M; Kawaguchi Y; Hosoya T
    Clin Nephrol; 2008 Feb; 69(2):121-6. PubMed ID: 18218305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS.
    Tseng CC; Chen JB; Wang IK; Liao SC; Cheng BC; Wu AB; Chang YT; Hung SY; Huang CC
    PLoS One; 2018; 13(1):e0190079. PubMed ID: 29293548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term impact of high-sensitivity C-reactive protein in patients with intermittent claudication due to peripheral artery disease following endovascular treatment.
    Fukase T; Dohi T; Kato Y; Chikata Y; Takahashi N; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Daida H; Minamino T
    Heart Vessels; 2021 Nov; 36(11):1670-1678. PubMed ID: 33956183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.
    Chung SH; Heimbürger O; Stenvinkel P; Qureshi AR; Lindholm B
    Nephrol Dial Transplant; 2003 Mar; 18(3):590-7. PubMed ID: 12584284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Predictive Value of High-Sensitivity C-Reactive Protein for Cancer Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    Endo H; Dohi T; Funamizu T; Shitara J; Wada H; Doi S; Naito R; Konishi H; Ogita M; Iwata H; Kasai T; Okazaki S; Isoda K; Shimada K; Miyauchi K; Daida H
    Circ J; 2019 Feb; 83(3):630-636. PubMed ID: 30541988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precedent fluctuation of serum hs-CRP to albumin ratios and mortality risk of clinically stable hemodialysis patients.
    Hwang JC; Jiang MY; Lu YH; Wang CT
    PLoS One; 2015; 10(3):e0120266. PubMed ID: 25793462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis.
    Lam MF; Leung JC; Lam CW; Tse KC; Lo WK; Lui SL; Chan TM; Tam S; Lai KN
    Perit Dial Int; 2008; 28(4):377-84. PubMed ID: 18556380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.